NCT00697112View on ClinicalTrials.gov

Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Renal Transplantation
Interventions
DRUG

Sirolimus

Non interventional. Sirolimus administered by Principal Investigator per standard practice and labeling.

Trial Locations (8)

1425

Pfizer Investigational Site, Caba

3000

Pfizer Investigational Site, Santa Fe

4000

Pfizer Investigational Site, San Miguel de Tucumán

5016

Pfizer Investigational Site, Barrio General Paz

Pfizer Investigational Site, Córdoba

C1093AAS

Pfizer Investigational Site, Caba

C1181ACH

Pfizer Investigational Site, Caba

Unknown

Pfizer Investigational Site, Caba

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY